Cannaponics Limited


Raising A$15M


A licensed producer of medicinal cannabis including cultivation, manufacturing and research company.

Business Highlights

Cannaponics is to build a 3,600sqm greenhouse along with a 2,000sqm EU GMP manufacture facility on its 160-acre freehold property in Collie WA, which will produce dried cannabis flower to be further processed into Cannaponics medicinal products. The whole project aims to use 100% renewable resources with Cannaponics subsidiary company CannaEnergy, building a 25,000 sqm solar electrical power hydrogen micro-grid with advanced water harvesting technology.

Business Segments 

A renewable resource, licensed producer for medicinal cannabis cultivation, manufacturing and research. The facility will be EU GMP compliant on our 160-acre freehold property in Collie, Western Australia.

A subsidiary company of Cannaponics, Hemponics is a food supplement and nutraceutical brand focused on providing high quality hemp-based products for the wellness and health food market. The companyHemponics will be our catalyst for over-the-counter CBD products.

Another subsidiary wholly owned by Cannaponics, CannaEnergy will use 100% renewable resources to power the Cannaponics facility, leveraging advanced technology via a 25,000sqm solar power and hydrogen electrical power micro-grid coupled with water harvesting technology.

Medika Health
An integrative Medical General Practice, 51% owned by Cannaponics, that offers evidence-based care for chronic diseases and preventative health alongside alternative and complementary medicine treatments.


Full Supply Chain Offering 

Growth Sector

First Mover Advantage

Key Information


Cannaponics is aiming to raise expansion capital to help build and operationalise its new facility:

  • Raising up to A$15M
  • Share Price: A$0.20
  • Minimum Investment: A$20,000

Use of Funds

  • Greenhouse build
  • Main office building
  • EU GMP facility and lab fit out
  • EU GMP extraction and manufacture equipment
  • Civil engineering and utilities
  • Security
  • Working capital


  • February 2022, The Hub new site will be built, commissioned and operational.
  • May 2022, the first harvest is expected.
  • July 2022, the first products are expected to be released


  • 2021 Information Memorandum


Hemponics Global | Evoking emotions of change to create a sustainable future (


    Ewave Signs Licence with Cannaponics

    Read more


    Rod Zakostelsky

    Founder & Managing Director
    Over 22 years of business ownership with involvement in many sectors including mining, health, construction, and personal wellness.

    Jay Stephenson

    Director and Company Secretary
    A qualified accountant who has been involved in business development for more than 30 years.

    Damian Wood

    Chief Operations Officer
    Registered pharmacist with 20 years’ experience in pharmaceutical manufacturing, clinical practice, and a sessional university academic

    Dr Stephen Chalk

    Medical Director
    A graduate of Oxford University and King’s College London, and a Fellow of the Royal Australian College of General Practitioners

    Eric J. Mathur

    Chief Scientist
    Over 40 years’ experience in applied biotechnology with a focus on translational science.

      Thank you for your enquiry.
      We will be in touch as soon as possible.